Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy Regardless of PD-L1 Status in a Specific Type of Lung Cancer in Phase III Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. MONRY
2. NYXH
3. TDY
4. PNR
5. ACN
6. ONON
7. IAUX
8. KKR
9. ORCL
10. LLY

Go back to Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy Regardless of PD-L1 Status in a Specific Type of Lung Cancer in Phase III Study
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 55.30 --0 (-0%)
Previous Close $55.30    52 Week High $35.13 
Open $55.30    52 Week Low $28.10 
Day High $55.30    P/E N/A 
Day Low $55.30    EPS $0.00 
Volume 205       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

ROGERS CORPORATION (NYSE: ROG) Delayed: 129.85 --0 (-0%)
Previous Close $129.85    52 Week High $76.55 
Open $129.85    52 Week Low $41.92 
Day High $129.85    P/E 73.36 
Day Low $129.85    EPS $1.77 
Volume 20